Search / Trial NCT06616324

Virtual Reality to Reduce Pain and Anxiety During Extracorporeal Shock Wave Lithotripsy

Launched by ZEALAND UNIVERSITY HOSPITAL · Sep 24, 2024

Trial Information

Current as of October 03, 2024

Not yet recruiting

Keywords

Virtual Reality Pain Anxiety Vr Eswl Extracorporeal Shock Wave Lithotripsy Lithotripsy Non Pharmacological

Description

The objective of this study is to evaluate the impact of intraprocedural Virtual Reality (VR) as a non-pharmacological intervention for mitigating anxiety and pain during Extracorporeal Shockwave Lithotripsy (ESWL). The hypothesis is that VR can effectively reduce both pain and anxiety levels in patients by diverting their cognitive focus, potentially leading to a decrease in pharmacological intervention requirements. Furthermore, the study aims to gather data on patients' perspectives regarding the functionality and efficacy of VR technology in enhancing their intraprocedural experience. ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Scheduled for ESWL at Region Zealand
  • * Age of 18 or above
  • * Ability to understand the trial protocol, risks, and benefits and provide signed informed consent
  • Exclusion Criteria:
  • * Inability to read and understand Danish.
  • * Uncooperativeness (as judged by investigators)
  • * Claustrophobia or fear of small spaces
  • * Disorders that prevent the person from wearing a VR device
  • * Highly visually or auditive impaired

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0